Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 676 clinical trials
Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence

Hepatocellular carcinoma(HCC) is prevalent in the hepatitis B virus(HBV) infection endemic areas. For early stage of HCC, surgical resection, radiofrequency ablation (RFA) or microwave ablation

  • 0 views
  • 19 Jul, 2021
  • 4 locations
Itacitinib in Advanced Hepatocellular Carcinoma (JAKaL)

This research will assess the effects of Itacitinib as a second line treatment for patients with advanced inflammatory hepatocellular carcinoma (HCC), a type of liver cancer. Itacinib is a

  • 0 views
  • 21 Jul, 2022
  • 1 location
The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

Lenvatinib(TKI) for the treatment of advanced hepatocellular carcinoma.

  • 0 views
  • 24 May, 2022
  • 1 location
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC

This is a prospective, one-arm, phase II clinical study of intravenous mFOLFOX6 plus Camrelizumab combined with apatinib for CNLC stage III hepatocellular carcinoma

  • 0 views
  • 13 Jun, 2022
  • 1 location
DEB-TACE+HAIC vs. HAIC for Large HCC

HAIC alone for unresectable large hepatocellular carcinoma (HCC).

  • 0 views
  • 10 Mar, 2022
  • 1 location
Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (DOSEY90)

This trial involves patients with hepatocellular carcinoma (HCC) diagnosis treated with transarterial radioembolization (TARE) with resin microspheres loaded with 90Y. Patients will be divided

  • 0 views
  • 23 Mar, 2022
  • 1 location
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

/metastatic HCC with Child-Pugh B7 liver disease who have received no prior systemic therapy.

  • 0 views
  • 05 Nov, 2021
  • 4 locations
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma

This study is an open, multi-center phase I/II clinical study.

  • 0 views
  • 14 May, 2021
  • 1 location
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Recurrent Hepatocellular Carcinoma

The purpose of this study is to investigate both the efficacy and safety of sintilimab combined with bevacizumab and radiotherapy in advanced recurrent hepatocellular carcinoma.

  • 0 views
  • 12 Sep, 2021
  • 1 location
GPC3-targeting LCAR-H93T Cell in Treatment of Advanced Hepatocellular Carcinoma

A Phase I Clinical Trial for Evaluating the Safety, Tolerance and Efficacy of GPC3-targeting LCAR-H93T Cell in Treatment of Advanced Hepatocellular Carcinoma

  • 0 views
  • 28 Jun, 2022
  • 1 location